Categories AlphaGraphs, Cannabis, Earnings
ACB Earnings: Aurora Cannabis reports narrower Q4 loss on higher revenues
Aurora Cannabis, Inc. (NASDAQ: ACB) on Thursday reported a net loss for the fourth quarter of 2024. The company’s revenues moved up 5% year-over-year during the quarter.
The Canada-based recreational marijuana company reported a net loss from continuing operations of C$20.8 million for the fourth quarter, compared to a loss of C$76.2 million in the prior-year period. Adjusted EBITDA was C$1.89 million during the three months, down 5% from the year-ago quarter. Total revenues increased 5% annually to C$67.4 million in Q4.
“Aurora is the largest global medical cannabis company in nationally legal markets and our leadership is best differentiated by serving the diverse needs of patients across the world. In Q4 2024, global medical cannabis net revenue1 increased 20% year-over-year, supported by the recent acquisition of MedReleaf Australia, where we saw significant growth, along with higher sales in Poland and the UK,” said Aurora’s CEO Miguel Martin.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
NKE Earnings: Nike Q4 2024 profit tops expectations; revenue down 2%
Nike, Inc. (NYSE: NKE) Thursday reported an increase in earnings for the fourth quarter of 2024, despite a decline in revenues. Earnings also beat estimates. Fourth-quarter net income came in
Constellation Brands (STZ) is preparing to report Q1 earnings. Here’s what to expect
As Constellation Brands, Inc. (NYSE: STZ) prepares to report first-quarter results, the focus is on the brewer’s impressive performance in the beer market. Recent data show that the business has
Key takeaways from McCormick’s (MKC) Q2 2024 earnings report
Shares of McCormick & Company, Incorporated (NYSE: MKC) rose over 4% on Thursday, after the company delivered better-than-expected earnings results for the second quarter of 2024. The stock has dropped
